About PRISM BioLab

PRISM BioLab Co., Ltd., based in Japan, is a biotechnology company with proprietary small molecule drug discovery technology.
The PRISM Library is designed to mimic α-helix or β-turn peptide using a unique stable scaffold with corresponding dihedral angles.
These motifs are essential for protein-protein interactions within the cell, especially related to transcription and translation.
Using our small molecule drug discovery technology, two clinical-stage assets for cancer and fibrosis have been developed and licensed to Japanese Pharma companies.
Many early lead molecules have also been created for novel or previously undruggable targets.